搜尋結果
MBX Biosciences seeks up to $482.5 mln valuation in US IPO
Reuters· 1 小時前MBX Biosciences, which is developing peptide therapies for treating endocrine and metabolic disorders, including obesity ...
George R.R. Martin Calls Out ‘Toxic’ Changes To ‘House Of The Dragon’
Forbes· 5 日前The man behind Game of Thrones and House of the Dragon has written a very public and very scathing critique of some of the ...
